OC-36 CD4 T-cell, CD4/CD8 ratio improvement and a general reduction in inflammatory biomarkers with low level viremia (LLV) up to week 192 with Fostemsavir (FTR) based regimens in individuals with multidrug-resistant (MDR) HIV-1

Abstract

BackgroundPersistent LLV (40–1000 copies/mL) remains a challenge in the era of high effective ART, which is associated with the emergence of virological failure, drug resistance and an increased risk of...